Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Virtual screening: a real screening complement to high-throughput screening.

J Mestres1

  • 1Computational Medicinal Chemistry, Organon Laboratories Ltd., Newhouse, Lanarkshire ML1 5SH, UK. j.mestres@organon.nhe.akzonobel.nl

Biochemical Society Transactions
|August 28, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation of QSAR models for predicting mutagenicity: outcome of the Second Ames/QSAR international challenge project.

SAR and QSAR in environmental research·2023
Same author

A multiscale orchestrated computational framework to reveal emergent phenomena in neuroblastoma.

Computer methods and programs in biomedicine·2023
Same author

Paving the way of systems biology and precision medicine in allergic diseases: the MeDALL success story: Mechanisms of the Development of ALLergy; EU FP7-CP-IP; Project No: 261357; 2010-2015.

Allergy·2016
Same author

Drug repurposing: far beyond new targets for old drugs.

The AAPS journal·2012
Same author

Linking pharmacology to clinical reports: cyclobenzaprine and its possible association with serotonin syndrome.

Clinical pharmacology and therapeutics·2011
Same author

MeDALL (Mechanisms of the Development of ALLergy): an integrated approach from phenotypes to systems medicine.

Allergy·2011
Same journal

TDP-43 proteinopathy as a biomarker and therapeutic target in amyotrophic lateral sclerosis.

Biochemical Society transactions·2026
Same journal

Advancing the monitoring of organelle contact sites in vitro and in vivo.

Biochemical Society transactions·2026
Same journal

Mechanisms influencing transient cytoplasmic protein targeting to intracellular lipid droplets.

Biochemical Society transactions·2026
Same journal

Replication associated nuclear DNA mismatch repair across kingdoms.

Biochemical Society transactions·2026
Same journal

Phosphatases of regenerating liver downregulate PTEN to promote tumorigenesis.

Biochemical Society transactions·2026
Same journal

Implications of Rho GTPase signaling in cancer immunotherapy.

Biochemical Society transactions·2026
See all related articles

Virtual screening is a key strategy for identifying drug candidates by prioritizing large collections and expanding screening to external databases. This study demonstrates its application in finding estrogen receptor alpha agonists.

Area of Science:

  • Computational chemistry
  • Drug discovery
  • Molecular modeling

Background:

  • Virtual screening is essential for modern hit identification.
  • It aids in prioritizing corporate screening libraries and external databases.
  • Estrogen receptor alpha (ER alpha) is a significant drug target.

Purpose of the Study:

  • To describe the core components of virtual screening.
  • To present an application of virtual screening for ER alpha agonist identification.

Main Methods:

  • Utilized computational methods for virtual screening.
  • Focused on identifying agonist hits for ER alpha.

Main Results:

  • Successfully applied virtual screening to identify potential ER alpha agonists.

Related Experiment Videos

  • Demonstrated the utility of virtual screening in drug discovery.

    • Conclusions:

    • Virtual screening is a powerful tool for hit identification.
    • The presented methodology is effective for targeting specific receptors like ER alpha.